Patients with mitral and tricuspid heart valve disease often have complex conditions with limited treatment options. Our Transcatheter Mitral and Tricuspid Therapies (TMTT) business unit is boldly pursuing an innovative portfolio of technologies to address a
You will make an impact by. • Serves as main point of contact within own business unit for assigned territory and/or customer base utilizing full understanding of hemodynamic monitoring and/or cardiovascular anatomy, pathology and physiology relevant